Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
39 participants
OBSERVATIONAL
2010-12-31
2011-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The NeXT Study; The Netherlands XTC Toxicity Study
NCT00235768
Prosocial Effects of MDMA
NCT05948683
Acute Effects of 3,4-methylenedioxymethamphetamine (MDMA) With and Without a Booster Dose
NCT05809271
Effects of MDMA and Methylphenidate on Social Cognition
NCT01616407
Effects of MDMA on Emotional and Social Memories
NCT03050541
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MDMA
poly drug users that used MDMA at New Years Eve
No interventions assigned to this group
Other Drugs
poly drug users that used drugs at New Years Eve, but not MDMA
No interventions assigned to this group
Alcohol
poly drug users that used no drugs at New Years Eve, but did consume alcohol
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18+ years old
Exclusion Criteria
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Utrecht Institute for Pharmaceutical Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Utrecht University
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Joris C Verster, PhD
Role: PRINCIPAL_INVESTIGATOR
Utrecht University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Utrecht University
Utrecht, Utrecht, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ppo-010-212
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.